Modification of asc1 by ufm1 is crucial for erα transactivation and breast cancer development

Molecular Cell

Volumn 56, Issue 2, 2014, Pages 261-274

  Yoo, Hee Min ^a   Kang, Sung Hwan ^a   Kim, Jae Yeon ^a   Lee, Joo Eun ^a   Seong, Min Woo ^a   Lee, Seong Won ^a   Ka, Seung Hyeun ^a   Sou, Yu Shin ^b   Komatsu, Masaaki ^b   Tanaka, Keiji ^b   Lee, Soon Tae ^a   Noh, Dong Young ^a   Baek, Sung Hee ^a   Jeon, Young Joo ^a   Chung, Chin Ha ^a  

^a Seoul National University   (South Korea)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING SIGNAL COINTEGRATOR 1 PROTEIN; ESTROGEN RECEPTOR ALPHA; NUCLEAR RECEPTOR COACTIVATOR; PROTEIN; SHORT HAIRPIN RNA; STEROID RECEPTOR COACTIVATOR 1; TAMOXIFEN; UBIQUITIN FOLD MODIFIER 1 PROTEIN; UNCLASSIFIED DRUG; AMINO ACID TRANSPORTER; ANTIESTROGEN; CARRIER PROTEIN; CYSTEINE PROTEINASE; E1A ASSOCIATED P300 PROTEIN; EP300 PROTEIN, HUMAN; ESTRADIOL; NCOA1 PROTEIN, HUMAN; PROTEIN BINDING; SLC7A10 PROTEIN, HUMAN; UBA5 PROTEIN, HUMAN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UFL1 PROTEIN, HUMAN; UFM1 PROTEIN, HUMAN; UFM1-BINDING PROTEIN 1 CONTAINING A PCI DOMAIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ARTICLE; BINDING SITE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CELL GROWTH; CELL LYSATE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; ENHANCER REGION; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIGAND BINDING; MASS SPECTROMETRY; MCF 7 CELL LINE; MOUSE; MTT ASSAY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROMOTER REGION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; STABLE EXPRESSION; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TUMOR XENOGRAFT; ANIMAL; BREAST TUMOR; CHEMISTRY; ENZYME ACTIVATION; GENETICS; HEK293 CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CYSTEINE ENDOPEPTIDASES; E1A-ASSOCIATED P300 PROTEIN; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; FEMALE; HEK293 CELLS; HUMANS; MCF-7 CELLS; MICE; MICE, NUDE; NUCLEAR RECEPTOR COACTIVATOR 1; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEINS; TAMOXIFEN; TRANSCRIPTIONAL ACTIVATION; UBIQUITIN; UBIQUITIN-ACTIVATING ENZYMES; UBIQUITIN-PROTEIN LIGASES;

EID: 84922329604     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2014.08.007     Document Type: Article

References (43)

1. Beelen, K., Zwart, W., and Linn, S.C. (2012). Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy? Nat. Rev. Clin. Oncol. 9, 529-541.
2. Carroll, J.S., Liu, X.S., Brodsky, A.S., Li, W., Meyer, C.A., Szary, A.J., Eeckhoute, J., Shao, W., Hestermann, E.V., Geistlinger, T.R., et al. (2005). Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122, 33-43.
3. Chen, C., Itakura, E., Weber, K.P., Hegde, R.S., and de Bono, M. (2014). An ER complex of ODR-4 and ODR-8/Ufm1 specific protease 2 promotes GPCR maturation by a Ufm1-independent mechanism. PLoS Genet. 10, e1004082.
4. Gannavaram, S., Sharma, P., Duncan, R.C., Salotra, P., and Nakhasi, H.L. (2011). Mitochondrial associated ubiquitin fold modifier-1 mediated protein conjugation in Leishmania donovani. PLoS ONE 6, e16156.
5. Green, K.A., and Carroll, J.S. (2007). Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nat. Rev. Cancer 7, 713-722.
6. Ha, B.H., Ahn, H.C., Kang, S.H., Tanaka, K., Chung, C.H., and Kim, E.E. (2008). Structural basis for Ufm1 processing by UfSP1. J. Biol. Chem. 283, 14893-14900.
7. Ha, B.H., Jeon, Y.J., Shin, S.C., Tatsumi, K., Komatsu, M., Tanaka, K., Watson, C.M., Wallis, G., Chung, C.H., and Kim, E.E. (2011). Structure of ubiquitin-fold modifier 1-specific protease UfSP2. J. Biol. Chem. 286, 10248-10257.
8. Hanstein, B., Eckner, R., DiRenzo, J., Halachmi, S., Liu, H., Searcy, B., Kurokawa, R., and Brown, M. (1996). p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. USA 93, 11540-11545.
9. Hassig, C.A., and Schreiber, S.L. (1997). Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr. Opin. Chem. Biol. 1, 300-308.
10. Hermanson, O., Glass, C.K., and Rosenfeld, M.G. (2002). Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol. Metab. 13, 55-60.
11. Hoeller, D., Hecker, C.M., and Dikic, I. (2006). Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat. Rev. Cancer 6, 776-788.
12. Jeon, Y.J., Yoo, H.M., and Chung, C.H. (2010). ISG15 and immune diseases. Biochim. Biophys. Acta 1802, 485-496.
13. Jozwik, K.M., and Carroll, J.S. (2012). Pioneer factors in hormone-dependent cancers. Nat. Rev. Cancer 12, 381-385.
14. Kang, S.H., Kim, G.R., Seong, M., Baek, S.H., Seol, J.H., Bang, O.S., Ovaa, H., Tatsumi, K., Komatsu, M., Tanaka, K., and Chung, C.H. (2007). Two novel ubiquitin-fold modifier 1 (Ufm1)-specific proteases, UfSP1 and UfSP2. J. Biol. Chem. 282, 5256-5262.
15. Kim, H.J., Yi, J.Y., Sung, H.S., Moore, D.D., Jhun, B.H., Lee, Y.C., and Lee, J.W. (1999). Activating signal cointegrator 1, a novel transcription coactivator of nuclear receptors, and its cytosolic localization under conditions of serum deprivation. Mol. Cell. Biol. 19, 6323-6332.
16. Klinge, C.M. (2001). Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 29, 2905-2919.
17. Komatsu, M., Chiba, T., Tatsumi, K., Iemura, S., Tanida, I., Okazaki, N., Ueno, T., Kominami, E., Natsume, T., and Tanaka, K. (2004). A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier. EMBO J. 23, 1977-1986.
18. Kulathu, Y., and Komander, D. (2012). Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat. Rev. Mol. Cell Biol. 13, 508-523.
19. Kwon, J., Cho, H.J., Han, S.H., No, J.G., Kwon, J.Y., and Kim, H. (2010). A novel LZAP-binding protein, NLBP, inhibits cell invasion. J. Biol. Chem. 285, 12232-12240.
20. Lee, J.W., Choi, H.S., Gyuris, J., Brent, R., and Moore, D.D. (1995). Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol. Endocrinol. 9, 243-254.
21. Lee, S.K., Anzick, S.L., Choi, J.E., Bubendorf, L., Guan, X.Y., Jung, Y.K., Kallioniemi, O.P., Kononen, J., Trent, J.M., Azorsa, D., et al. (1999). A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J. Biol. Chem. 274, 34283-34293.
22. Lee, Y.S., Kim, H.J., Lee, H.J., Lee, J.W., Chun, S.Y., Ko, S.K., and Lee, K. (2002). Activating signal cointegrator 1 is highly expressed in murine testicular Leydig cells and enhances the ligand-dependent transactivation of androgen receptor. Biol. Reprod. 67, 1580-1587.
23. Lee, D.Y., Teyssier, C., Strahl, B.D., and Stallcup, M.R. (2005). Role of protein methylation in regulation of transcription. Endocr. Rev. 26, 147-170.
24. Lemaire, K., Moura, R.F., Granvik, M., Igoillo-Esteve, M., Hohmeier, H.E., Hendrickx, N., Newgard, C.B., Waelkens, E., Cnop, M., and Schuit, F. (2011). Ubiquitin fold modifier 1 (UFM1) and its target UFBP1 protect pancreatic beta cells from ER stress-induced apoptosis. PLoS ONE 6, e18517.
25. Lonard, D.M., and O'Malley, B.W. (2007). Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol. Cell 27, 691-700.
26. Mahajan, M.A., and Samuels, H.H. (2000). A new family of nuclear receptor coregulators that integrate nuclear receptor signaling through CREB-binding protein. Mol. Cell. Biol. 20, 5048-5063.
27. Mahajan, M.A., and Samuels, H.H. (2005). Nuclear hormone receptor coregulator: role in hormone action, metabolism, growth, and development. Endocr. Rev. 26, 583-597.
28. Mizushima, T., Tatsumi, K., Ozaki, Y., Kawakami, T., Suzuki, A., Ogasahara, K., Komatsu, M., Kominami, E., Tanaka, K., and Yamane, T. (2007). Crystal structure of Ufc1, the Ufm1-conjugating enzyme. Biochem. Biophys. Res. Commun. 362, 1079-1084.
29. Neziri, D., Ilhan, A., Maj, M., Majdic, O., Baumgartner-Parzer, S., Cohen, G., Base, W., and Wagner, L. (2010). Cloning and molecular characterization of Dashurin encoded by C20orf116, a PCI-domain containing protein. Biochim. Biophys. Acta 1800, 430-438.
30. Nilsson, S., Mä kelä, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., and Gustafsson, J.A. (2001). Mechanisms of estrogen action. Physiol. Rev. 81, 1535-1565.
31. Nilsson, S., Koehler, K.F., and Gustafsson, J.A. (2011). Development of subtype-selective oestrogen receptor-based therapeutics. Nat. Rev. Drug Discov. 10, 778-792.
32. Sasakawa, H., Sakata, E., Yamaguchi, Y., Komatsu, M., Tatsumi, K., Kominami, E., Tanaka, K., and Kato, K. (2006). Solution structure and dynamics of Ufm1, a ubiquitin-fold modifier 1. Biochem. Biophys. Res. Commun. 343, 21-26.
33. Schulman, B.A., and Harper, J.W. (2009). Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat. Rev. Mol. Cell Biol. 10, 319-331.
34. Shao, W., Keeton, E.K., McDonnell, D.P., and Brown, M. (2004). Coactivator AIB1 links estrogen receptor transcriptional activity and stability. Proc. Natl. Acad. Sci. USA 101, 11599-11604.
35. Smith, C.L., Oñate, S.A., Tsai, M.J., and O'Malley, B.W. (1996). CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc. Natl. Acad. Sci. USA 93, 8884-8888.
36. Tatsumi, K., Sou, Y.S., Tada, N., Nakamura, E., Iemura, S., Natsume, T., Kang, S.H., Chung, C.H., Kasahara, M., Kominami, E., et al. (2010). A novel type of E3 ligase for the Ufm1 conjugation system. J. Biol. Chem. 285, 5417-5427.
37. Tatsumi, K., Yamamoto-Mukai, H., Shimizu, R., Waguri, S., Sou, Y.S., Sakamoto, A., Taya, C., Shitara, H., Hara, T., Chung, C.H., et al. (2011). The Ufm1-activating enzyme Uba5 is indispensable for erythroid differentiation in mice. Nat Commun 2, 181.
38. Umar, A., Dunn, B.K., and Greenwald, P. (2012). Future directions in cancer prevention. Nat. Rev. Cancer 12, 835-848.
39. Wu, H., Sun, L., Zhang, Y., Chen, Y., Shi, B., Li, R., Wang, Y., Liang, J., Fan, D., Wu, G., et al. (2006). Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation. J. Biol. Chem. 281, 21848-21856.
40. Wu, J., Lei, G., Mei, M., Tang, Y., and Li, H. (2010). A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling. J. Biol. Chem. 285, 15126-15136.
41. Xu, J., Wu, R.C., and O'Malley, B.W. (2009). Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat. Rev. Cancer 9, 615-630.
42. Zhang, Y., Zhang, M., Wu, J., Lei, G., and Li, H. (2012). Transcriptional regulation of the Ufm1 conjugation system in response to disturbance of the endoplasmic reticulum homeostasis and inhibition of vesicle trafficking. PLoS ONE 7, e48587.
43. Zheng, M., Gu, X., Zheng, D., Yang, Z., Li, F., Zhao, J., Xie, Y., Ji, C., and Mao, Y. (2008). UBE1DC1, an ubiquitin-activating enzyme, activates two different ubiquitin-like proteins. J. Cell. Biochem. 104, 2324-2334.